Evidence map›Paper›PMID 42218286›Full record

ArticleScientific reports2026

PromptSE: drug side effect prediction with LLM-derived pharmacological representations.

Yuqing Xia, Hao Wang, Tianyi Li, Yilong Niu

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuqing XiaSchool of Data Sciences, Zhejiang University of Finance and Economics, Hangzhou, 310018, China. yuqing.xia@zufe.edu.cn.
Hao WangSchool of Data Sciences, Zhejiang University of Finance and Economics, Hangzhou, 310018, China.
Tianyi LiSchool of Data Sciences, Zhejiang University of Finance and Economics, Hangzhou, 310018, China.
Yilong NiuSchool of Data Sciences, Zhejiang University of Finance and Economics, Hangzhou, 310018, China.

Funding

National Natural Science Foundation of China No.12401500Zhejiang Provincial Natural Science Foundation of China No.LQ21F020023
6 · The paper itself

Abstract

Predicting drug-side effect associations is vital for drug discovery and patient safety. Accurate prediction requires high-quality representations of both drugs and side effects. While drug representations have advanced due to rich structured data, side effect information is mostly unstructured, symptom-oriented and heterogeneous texts, making it hard to capture underlying pharmacological mechanisms. We propose prompt-based side effect prediction (PromptSE), a hybrid framework that combines the reasoning power of large language models with the predictive capability of deep learning. PromptSE employs stepwise prompting tailored to the characteristics of side effect texts, moving beyond simple encoding or conventional prompting, to generate pharmacologically relevant representations. These representations are then fed into a deep learning module for drug-side effect prediction. Building on this framework, PromptSE+ extends the prediction module by integrating multi-modal drug information. Rare entity representations are further refined via a custom graph neural network module. Experiments show that PromptSE outperforms non-drug-informed baselines by 9.26% in AUPR, confirming the effectiveness of our representations. PromptSE+ enhances state-of-the-art drug-side effect prediction methods across all metrics, including a 1.81% AUPR gain, demonstrating its compatibility with advanced methods and potential to support safer drug development and more reliable pharmacological research.

Indexed as

Deep LearningDrug-Related Side Effects and Adverse ReactionsDrug DiscoveryGraph Neural NetworksHumansLarge Language ModelsPrediction AlgorithmsPredictive Learning Models

Identifiers

PMID42218286
PMCPMC13458511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.